Javier A Menendez
Javier A Menendez is an expert in Oncology at Institut Català d'Oncologia (Spain). As of July 2026, ScienceLeadR ranks Javier A Menendez in the top 1% of experts worldwide for Breast Diseases and Breast Neoplasms. Javier A Menendez has authored 420 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 1,507 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 420
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Silibinin is a natural molecular glue that inhibits PD-L1 glycomaturation. PMID 42365692 — cells, silybin, neoplasms, immunotherapy, plants, medicinal, herbal medicine | Phytomedicine | 2026 | 1 |
| Fatty acid synthesis therapy-induced senescence (FASTIS) in cancer cells. PMID 42309995 — cells, neoplasms, sterols, cholesterol, therapeutics, cell death, fatty acids | Cell Death Dis | 2026 | 0 |
| Epigenetic Clocks in the Cosmic Silence of a Deep Underground Laboratory: Implications for Aging and Space Exploration. PMID 42295084 — laboratories, aging | Aging Dis | 2026 | 0 |
| Cellular Senescence in the Absence of Galactic Cosmic-Ray Muons. PMID 42234970 — cells, absenteeism, stress, physiological, cellular senescence, phenotype | Aging Dis | 2026 | 0 |
| Characterising Epigenetic Tipping Points using a Spectral Dimension Reduction Approach. PMID 41849043 — cells, genes, chromatin, enzymes, mathematics | Bull Math Biol | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map